Natriumchlorid, Viaflo Baxter (Sodium Chloride)

The sodium chloride in the injection provides Na+ and Cl‑ ions that increase extracellular osmolarity. This draws water from the intracellular and interstitial spaces into the bloodstream, expanding plasma volume and correcting low sodium or chloride levels, thereby restoring normal fluid balance.

The dose of Natriumchlorid, Viaflo Baxter is determined by the prescribing clinician based on the patient’s fluid status, electrolyte levels, and clinical condition. The healthcare professional calculates the appropriate volume and rate of infusion to safely achieve the desired therapeutic effect.

Safety data for Natriumchlorid, Viaflo Baxter in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Natriumchlorid, Viaflo Baxter is a standard isotonic saline solution (0.9% NaCl) that provides only sodium and chloride ions. Compared with balanced electrolyte solutions, it lacks additional buffers such as lactate or acetate, making it suitable when a simple sodium chloride replacement is desired.

The product should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Maintain the original packaging until use to preserve sterility and solution integrity.

It is administered intravenously by a qualified healthcare professional. The solution is typically infused through a peripheral or central venous line, with the rate and volume adjusted according to the patient’s clinical needs and monitoring parameters.

Serious risks include severe hypernatremia, pulmonary edema from fluid overload, cardiac arrhythmias due to electrolyte imbalance, and rare anaphylactic reactions. Continuous monitoring of fluid status and serum electrolytes helps mitigate these risks.

Patients with known hypersensitivity to sodium chloride solutions, uncontrolled heart failure, severe renal impairment, or those at high risk for fluid overload should avoid this product unless a healthcare provider determines that the benefits outweigh the risks.